FR5334M - - Google Patents

Info

Publication number
FR5334M
FR5334M FR51392A FR51392A FR5334M FR 5334 M FR5334 M FR 5334M FR 51392 A FR51392 A FR 51392A FR 51392 A FR51392 A FR 51392A FR 5334 M FR5334 M FR 5334M
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR51392A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Application granted granted Critical
Publication of FR5334M publication Critical patent/FR5334M/fr
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/099Bordetella

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Transmission And Conversion Of Sensor Element Output (AREA)
FR51392A 1964-12-11 1966-02-28 Expired FR5334M (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US417828A US3395219A (en) 1964-12-11 1964-12-11 Process for production of pertussis antigen

Publications (1)

Publication Number Publication Date
FR5334M true FR5334M (fr) 1967-08-28

Family

ID=23655548

Family Applications (2)

Application Number Title Priority Date Filing Date
FR1561060D Expired FR1561060A (fr) 1964-12-11 1965-12-01
FR51392A Expired FR5334M (fr) 1964-12-11 1966-02-28

Family Applications Before (1)

Application Number Title Priority Date Filing Date
FR1561060D Expired FR1561060A (fr) 1964-12-11 1965-12-01

Country Status (12)

Country Link
US (1) US3395219A (fr)
BE (1) BE673564A (fr)
BR (1) BR6575449D0 (fr)
DE (1) DE1492042A1 (fr)
DK (1) DK114572B (fr)
ES (1) ES320879A1 (fr)
FR (2) FR1561060A (fr)
GB (1) GB1108906A (fr)
IL (1) IL24715A (fr)
NL (1) NL6516118A (fr)
NO (1) NO117493B (fr)
SE (1) SE318672B (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2461439C3 (de) * 1974-12-24 1980-03-20 Behringwerke Ag, 3550 Marburg Verfahren zur Herstellung eines schützenden Antigens von Bordetella Pertussis sowie jenes enthaltendes Mittel
JPS52134018A (en) * 1976-04-30 1977-11-09 Behringwerke Ag Antigen for protecting pertussis and vacczne containing same
FR2393065A1 (fr) * 1977-05-31 1978-12-29 Merieux Inst Procede de separation de lipides d'endotoxines bacteriennes et notamment d'endotoxine de bordetella pertussis
NZ188211A (en) * 1977-10-28 1984-09-28 American Cyanamid Co Isolation of polyribosyl ribitol phosphate(prp)from haemophilus influenzae type b;vaccine comprising prp and bordetellapertussis antigens
DE2961293D1 (en) * 1978-02-17 1982-01-14 Nat Res Dev Immunogenic cell envelope preparations
US4247452A (en) * 1978-03-01 1981-01-27 The Secretary Of State For Defence In Her Britannic Majesty's Government Of The United Kingdom Of Great Britain And Northern Ireland Purification of pertussis haemagglutinins
FR2460139A1 (fr) * 1979-06-29 1981-01-23 Pasteur Institut Fraction antigenique glycopeptidique vaccinante a tres grande immunogenicite isolee de cultures de germes pathogenes, procedes d'isolement de cette fraction et vaccins contenant ladite fraction
US4338299A (en) * 1980-11-17 1982-07-06 Dso "Pharmachim" Vaccine against pertussis
US4474758A (en) * 1981-11-19 1984-10-02 American Cyanamid Company Haemophilus influenzae type b and pertussis outer membrane component combined vaccine
HU188847B (en) * 1983-02-22 1986-05-28 Human Oltoanyagtermeloe Es Kutato Intezet,Hu Process for producing liophylized combined vaccines
GB8412207D0 (en) * 1984-05-12 1984-06-20 Wellcome Found Antigenic preparations
US5237052A (en) * 1984-05-12 1993-08-17 Burroughs Wellcome Company Antigenic preparations and isolation of such preparations
US4981685A (en) * 1986-03-07 1991-01-01 Utah State University Foundation Bacterial extract vaccines for veterinary application

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2965543A (en) * 1953-07-03 1960-12-20 Merck & Co Inc Alcohol detoxification of pertussis vaccines

Also Published As

Publication number Publication date
DK114572B (da) 1969-07-14
BR6575449D0 (pt) 1973-09-06
NO117493B (fr) 1969-08-18
GB1108906A (en) 1968-04-10
BE673564A (fr) 1966-06-10
US3395219A (en) 1968-07-30
DE1492042A1 (de) 1969-05-14
ES320879A1 (es) 1966-10-01
IL24715A (en) 1969-11-12
FR1561060A (fr) 1969-03-28
SE318672B (fr) 1969-12-15
NL6516118A (fr) 1966-06-13

Similar Documents

Publication Publication Date Title
FR1561060A (fr)
AU442366B2 (fr)
BE642735A (fr)
BE432268A (fr)
BE637777A (fr)
BE637950A (fr)
BE47396A (fr)
BE653891A (fr)
BE655606A (fr)
BE642104A (fr)
BE483969A (fr)
BE627390A (fr)
BE642114A (fr)
BE627931A (fr)
BE642212A (fr)
BE642243A (fr)
BE507097A (fr)
BE518974A (fr)
BE642316A (fr)
BE642367A (fr)
BE554195A (fr)
BE564626A (fr)
BE642395A (fr)
BE642400A (fr)
BE642437A (fr)